Tacrolimus and Nerve Growth factor Treated Allografts for Neural Tissue Regeneration.

Yixia Yin,Gao Xiao,Kaiming Zhang,Guoliang Ying,Haixing Xu,Bruna A G De Melo,Shipu Li,Fang Liu,Ali K Yetisen,Nan Jiang

DOI: https://doi.org/10.1021/acschemneuro.8b00452

2019-01-01

ACS Chemical Neuroscience

Abstract:Treatment of injured peripheral nerve, especially the long-distant nerve defect remains a significant challenge in regenerative medicine due to complex biological conditions and lack of biomaterials for effective nerve reconstruction. Without proper treatment, the injury to nerve leads to motor and sensory dysfunction. Here, we have developed an efficacious nerve allograft treated with dual drug containing Tacrolimus (FK506) and nerve growth factor (NGF) to bridge the nerve gap and achieve rapid neural tissue recovery without immunological rejection. The nerve recovery of structure, activity, and function of rats treated with the dual drug treated allograft is investigated by walking track analysis and electrophysiological measurement. The sciatic functional index is measured to be -3.0 after 12-week treatment. The nerve conduction velocity, peak latency, and peak amplitude of the nerve action potentials demonstrate the nerve functional recovery. To study the synergistic effect of dual drug on the growth of neuritis, a neural cell hypoxic model was created. The dual drug exhibited the high efficiency to promote the growth of nerve cells under the nerve injury-induced hypoxic condition. The dual drug could provide protection of the cells against anti-oxidative damage from hypoxia by the expression of heat shock protein, hypoxia-inducible factor, β-tubulin, and vimentin. e principal findings, and point out major conclusions.